Company news
Embecta Corp. (NASDAQ:EMBC) news
Embecta Corp. news releases on 6ix. Latest, Aug 7, 2026: Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
Press releases & updates
Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
August 7, 2026
embecta to Report Fiscal Third Quarter Financial Results
July 23, 2026
embecta appoints Nimish Muzumdar as SVP and President, North America
June 16, 2026
embecta Completes Acquisition of Owen Mumford Holdings Limited
May 15, 2026
embecta to Participate at the 2026 BofA Securities Global Health Care Conference
May 8, 2026
Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results
May 5, 2026
embecta to Report Fiscal Second Quarter Financial Results
April 21, 2026
embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited
March 18, 2026
embecta names new Chairman of the Board and Lead Independent Director
February 11, 2026
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results
February 5, 2026
embecta Announces Quarterly Cash Dividend
February 4, 2026
embecta to Report Fiscal First Quarter Financial Results
January 21, 2026
embecta to Participate at the J.P. Morgan 2026 Healthcare Conference
December 17, 2025
Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance
November 24, 2025
embecta announces changes to Board of Directors
November 16, 2025
embecta Announces Major New Commitment to Direct Relief on World Diabetes Day
November 13, 2025
embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results
November 10, 2025
embecta to Participate in Investor Events
August 25, 2025
Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results
August 7, 2025
embecta to Report Fiscal Third Quarter 2025 Financial Results
July 23, 2025
embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day
May 21, 2025
Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results
May 8, 2025
Embecta to host Analyst and Investor Day on May 22, 2025
April 27, 2025
embecta to Report Fiscal Second Quarter 2025 Financial Results
April 20, 2025
embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference
February 17, 2025
Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results
February 5, 2025
embecta to Report Fiscal First Quarter 2025 Financial Results
January 22, 2025
embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs
November 25, 2024
embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
November 11, 2024
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
November 6, 2024
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
September 2, 2024
Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results
August 8, 2024
embecta to Report Fiscal Third Quarter 2024 Financial Results
July 17, 2024
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
June 23, 2024
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results
May 8, 2024
embecta to Report Fiscal Second Quarter 2024 Financial Results
April 22, 2024
embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
March 5, 2024
Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results
February 8, 2024
embecta to Participate in the 11th Annual BTIG MedTech Conference
February 6, 2024
embecta to Report Fiscal First Quarter 2024 Financial Results
January 23, 2024
embecta Announces FDA 510(k) Submission for Insulin Patch Pump
January 8, 2024
embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
December 13, 2023
No embecta-made syringes impacted by FDA safety communication
November 30, 2023
embecta to Participate in Investor Conferences
November 28, 2023
Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance
November 20, 2023
embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell
October 30, 2023
embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results
October 24, 2023
embecta to Participate at the Morgan Stanley 21st Annual Healthcare Conference
September 5, 2023
Embecta Corp. Reports Third Quarter Fiscal 2023 Financial Results
August 7, 2023